Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Zura Bio Ltd (ZURA) Balance Sheet

As of 2026-06-30 (10-Q), Zura Bio Ltd (ZURA) reported total assets of $213.4M, total liabilities of $16.3M and shareholders' equity of $197.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $205134.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ZURAZura Bio LtdFollow ZURA — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
322.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
18 Nov, in 25 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents0.71.699.80.20.10.2
Current assets1.21.8100.8178.7112.3210.5
Total assets140.65.3100.8179.5113.9213.4
Current liabilities0.314.820.319.512.416.3
Total liabilities10.414.821.319.512.416.3
Shareholders' equity-9.2-32.160.9148.4101.5197.1

USD millions · SEC XBRL

Zura Bio Ltd — questions

How much cash does Zura Bio Ltd have?
$205134 in cash and cash equivalents as of 2026-06-30.
What are Zura Bio Ltd's total assets?
$213.4M as of 2026-06-30.
What is Zura Bio Ltd's shareholders' equity?
$197.1M as of 2026-06-30.

Every figure on this page comes from Zura Bio Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.